NPPA Panel Suggests Retail Price of Atorvastatin,Bempedoic Acid FDC Marketed By Zydus Healthcare Dr. Divya Colin28 Oct 2022 6:00 PM IST New Delhi: The National Pharmaceutical Pricing Authority (NPPA) Committee has suggested the retail price of each film coated tablet containing...
NPPA fixes retail price of 40 formulations including Dapagliflozin-metformin FDC Susmita Roy3 Oct 2022 4:00 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India,...
Conduct Phase II CT : CDSCO panel opines Zydus Pharma over Hepatitis E Vaccine Dr. Divya Colin14 Sept 2022 6:00 PM ISTNew Delhi: The Subject Expert Committee(SEC) functional under the Central Drug Standard Control Organization(CDSCO) has opined the pharma major Zydus...
Zydus Lifesciences Topical acne treatment gel gets USFDA okay Ruchika Sharma7 Jun 2022 1:10 PM ISTThe drug will be manufactured at group’s topical facility at Ahmedabad.
Zydus Lifesciences gets USFDA nod for Pulmonary Arterial Hypertension drug Selexipag Ruchika Sharma6 May 2022 3:03 PM ISTThe drug will be manufactured at group’s formulation facility at SEZ, Ahmedabad.
Zydus gets USFDA Prior Approval Supplement (PAS) approval for Mycophenolate Mofetil for Injection USP MD Bureau21 March 2022 4:41 PM ISTThe injection will be manufactured at the groups injectables manufacturing facility at Jarod near Vadodara in Gujarat.
Zydus Lifesciences gets USFDA nod for Colestipol Hydrochloride Tablets MD Bureau16 March 2022 3:41 PM ISTColestipol hydrochloride tablets are indicated as adjunctive therapy to diet for the reduction of elevated serum total and LDL-C in patients with...
Zydus gets DCGI nod for Oxemia MD Bureau8 March 2022 2:05 PM ISTThe clinical development programme of Desidustat was one of the largest trials of its kind in India for Anemia in CKD patients, conducted in over...
Zydus to launch Desidustat breakthrough treatment for Anemia in CKD patients under brand name Oxemia MD Bureau7 March 2022 12:04 PM ISTOxemia is an oral, small molecule hypoxia-inducible factor-prolyl hydroxylase (HIF-PH) inhibitor.
Health Bulletin 25/February/2022 Roshni Dhar25 Feb 2022 4:26 PM ISTHere are Health stories of the dayNMC releases TEQ qualifications in Medical Institutions Regulations 2022Comprehensively laying down out the...
Cadila Healthcare is now Zydus Lifesciences Ruchika Sharma24 Feb 2022 6:08 PM ISTNew Delhi: The Zydus group announced its new brand identity with the listed entity of the group Cadila Healthcare Ltd. to be known as Zydus...
USFDA nod to Zydus to market generic version of Vigabatrin Dr. Divya Colin21 Jan 2022 4:02 PM ISTThe approval by the US Food and Drug Administration is for Vigabatrin tablets of 500 mg strength, Cadila Healthcare said in a regulatory filing.
